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Abstract 
 
This paper investigates Critical Success Factors (CSFs) that affect the performance of 
organisations involved in medical technology supply chains (MTSCs) in Germany. 
German medical technology is an innovative and fast-growing industry, which is 
currently under pressure to reduce costs. This paper presents an exploratory research 
involving a multiple case study. Six, prioritised CSFs for OEMs within MTSCs that 
include sales and operations planning, product development process, as well as quality 
and compliance were identified through empirical research. These findings challenge 
existing assumptions about CSFs within MTSCs, providing practitioners with strategies 
that should help to improve operational performance of OEMs. 
 
Keywords: Supply chain network design and analysis, Collaboration and coordination 
issues in SCM, Medical technology industry 
 
 
Introduction 
Medical technology is any technology applied to save the lives of people affected by a 
wide range of conditions and ranges from mass production items such as sticking 
plasters, syringes or latex gloves, to specific equipment such as wheelchairs and hearing 
aids, to high-tech devices such as pacemakers, replacement joints for knees and hips, to 
intelligent contact lenses (Eucomed, 2015). Medical technology is considered to be an 
innovative, fast-growing and promising industry, particular so in Germany as it is the 
third largest market in the world behind the United States of America and Japan, 
(BVMed, 2015) In addition to some large companies, around 1,200 small and medium-
sized enterprises (SMEs) constitute the core of the sector (BVMed, 2015). In 2014, the 
total volume of medical technology manufacturing organisations increased by 2.3% to 
25.2 billion euros; domestic sales rose 3% to 8.1 billion euros, while international sales 
increased by 2.3% to a total of 17.1 billion euros (BVMed, 2015). Despite this 
impressive growth, the medical technology industry in Germany has suffered several 
setbacks in recent years. Germany’s statutory health insurance fund (gesetzliche 
 2 
 
Krankenversicherung) has experienced funding difficulties, forcing administrators to 
reduce schedule fees and thus expenditures on medical technology (Hartford, 2014). 
Moreover, the German government is targeting this industry as part of budgetary 
savings, leading to major cuts in research programmes (EY, 2013). Furthermore, 
Chinese companies are also gaining technological expertise and are on their way to 
become global leaders in research and design over the next decade. Studies (J & M, 
2010; Mayr, 2013) show that a defined supply chain strategy often falls short in this 
sector. Therefore, understanding which key features lead to better performance of 
organisations within Medical Technology Supply Chains (MTSCs) is imperative.  
In this paper, we investigate multiple cases of OEMs involved in MTSCs and use the 
results of the analysis to identify those Critical Success Factors (CSFs) that that 
practitioners in the field prioritise in pursuing opportunities and areas of improvement 
which require addressing during the design and implementation of Supply Chain 
Management (SCM) strategies. These findings are then fully discussed in the light of 
the extant literature. This paper is organised as follows. First, a review of the literature 
is reported. Then, the methodology and case study design are presented. This is 
followed by the analysis and discussion of the findings. Finally, this paper concludes 
with the implications for theory and management practice along with research 
limitations and avenues for further research. 
 
Literature review 
Supply chain management as an area in operations management literature is extremely 
well served whereas there is a real dearth regarding its focus on medical technology 
supply chains and their agility as exemplified by recent literature (Gligor, 2014; 
Mandal, 2017).  
Mentzer et al (2001) define supply chains as a “set of three or more entities directly 
involved in the upstream and downstream flow of products, services, finances, and 
information from a source to the customer”. There are three major players in the 
healthcare supply chain: producers (product manufacturers), purchasers (group 
purchasing organisations, or GPOs, and wholesalers/distributors), and health care 
providers (hospital systems and integrated delivery networks, or IDNs) (Burns & al, 
2002). McCurry et al (2005) provides a detailed view of the healthcare supply chain 
(see Figure 1).  
 
 
Figure 1: Detailed view of product, information and cash flows in the healthcare supply chain 
(McCurry et al,2005) 
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This view is extended to include financial flows as well, underlining the heavy 
influence of intermediaries or third-party players. Studies by Burns (2000), J and M 
Research (2010), and Mayr (2013) indicate that a significant portion of the costs 
associated with supply chains in the health care sector can be reduced by adopting 
strategies already deployed by the industry sector. In order to provide guidelines for 
practitioners to adopt the necessary organisational changes, the identification of critical 
success factors becomes very important. 
 
Critical success factors in Supply Chain Management 
There are certain key elements in business that, if working properly, can ensure 
successful competitive performance for an organisation (Rockart, 1979). Rockart (1979) 
called these key areas critical success factors (CSFs) and defined them as “areas or 
activities that should receive constant and careful attention from management”. CSFs 
are used, for example, to identify critical issues in planning implementation, to achieve 
better organisational performance, to assist managers to execute a better resource 
allocation, and to serve as guidelines to monitor an organisation’s activities (Talib & 
Hamid, 2014; Boynton & Zmud, 1984).  
Early applications of CSFs in logistics and SCM were first found in studies such as 
Cooper and Ellram (1993), Chiu (1995), and Tate (1995). In the field of SCM, 
Gunasekaran and Ngai (2003) designed a framework for developing an efficient 3PL 
system, with factors such as ‘strategic planning’, ‘inventory management’, 
‘transportation planning’, ‘capacity planning’, and ‘information management’ as the 
major dimensions. Tummala et al (2006) discovered that resource allocation could be 
enhanced in areas such as information systems, goal-setting, training, personnel, and 
aligning SCM initiatives with current priorities and committed resources. Hu and Hsu 
(2010) employed a survey on the electronics industry in Taiwan to identify 20 critical 
factors for implementing green SCM, which were then clustered into four dimensions: 
‘supplier management’, ‘product recycling’, organisation involvement’, and ‘life cycle 
management’.  Finally, Talib and Hamid (2014) conducted a literature survey of 42 
studies and proposed four major CSFs in SCM: ‘collaborative partnership’, ‘information 
technology’, ‘top management support’, and ‘human resources’. 
 
Critical success factors in the medical technology industry 
Research on critical success factors in the medical technology industry has been focused 
towards medical device development, as companies in this market face intense 
competition, higher degrees of customer sophistication, and where the cost of medical 
devices greatly influences healthcare systems (Medina et al, 2013). Medina et al (2012) 
distinguishes between internal and external factors influencing medical device 
development. Internal factors focus on the organisational context within which design is 
carried out. Lucke et al (2009) cite the level of experience of designers as a major 
internal factor. In contrast, external factors relate mostly to cost and profit, research and 
development (R&D), clinical research, and insurance companies’ reimbursement 
(Medina et al, 2013). Intellectual property protections and overseas market opportunities 
are identified, among others, as external factors (Medina et al, 2013).  Finally, the Food 
and Drug Administration (FDA), the regulatory agency of medical devices marketed in 
the Unites States, is suggested as the primary external factor influencing companies’ 
development priorities (Medina et al, 2013). To date, there has been no specific study 
on CSFs related to MTSCs available in the SCM literature. This paper directly 
addresses this urgent need from both the academic and practitioner perspectives. 
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Research methodology 
An exploratory research design was deployed, with a multiple case study approach 
selected, as the literature review revealed limited insights concerning CSFs in MTSCs. 
In such an embryonic research field, a qualitative research based on case studies can 
provide better means to identify patterns and develop theory, especially if the 
relationships between the constructs are undefined (Edmondson & McManus, 2007). As 
researchers are able to interact with respondents, perspectives are better understood and 
relevant processes can be closely investigated (Boyer & Swink, 2008). For these 
reasons, we followed established methodological guidelines for case study research 
(Eisenhardt, 1989; Yin, 2009). This study was driven by the following research 
question: 
 What are the Critical Success Factors (CSFs) for Original Equipment 
Manufacturers (OEMs) in German Medical Technology Supply Chains (MTSCs)? 
Fifteen in-depth case studies of manufacturing organisations were conducted to 
obtain a greater understanding of the main issues of German MTSCs.  Table 1 provides 
a summary of the participating organisations.  
 
Table 1: Summary of the respondent demographics 
 
Nr. Company Classification according to 
the GMDN Agency (2012) 
1 
Position of respondent Company size 
according to IfM 
(2017) 2 
Number of 
employees 
1 A Laboratory equipment Vice President of Supply Chain 
Small and Medium 
Enterprise (SME) 
300 
2 B 
Electromechanical medical 
technology 
Vice President Global Logistics Large Enterprise (LE) 53 000 
3 C 
Electromechanical medical 
technology 
Manager of Logistics Planning Large Enterprise (LE) 12 500 
4 D 
Non-active implantable 
technology 
Director of Supply Chain 
Management 
Large Enterprise (LE) 3 400 
5 E 
Electromechanical medical 
technology 
Head of Supply Chain Large Enterprise (LE) 6 000 
6 F Reusable instruments Manager of Logistics Planning Large Enterprise (LE) 4 400 
7 G Hospital hardware 
Vice President of Global 
Logistics 
Large Enterprise (LE) 6 300 
8 H Biological-derived devices Manager of Global Logistics Large Enterprise (LE) 600 
9 I 
Non-active implantable 
technology 
Vice President of Supply Chain 
Small and Medium 
Enterprise (SME) 
180 
10 J 
Electromechanical medical 
technology 
Head of Supply Chain 
Operations 
Small and Medium 
Enterprise (SME) 
400 
11 K 
Diagnostic and therapeutic 
radiation technology 
Director of Supply Chain 
Management 
Large Enterprise (LE) 49 000 
12 L Single use technology Director of Supply Chain 
Small and Medium 
Enterprise (SME) 
500 
13 M 
Healthcare facility products and 
systems adaptations 
Head of Supply Chain 
Small and Medium 
Enterprise (SME) 
200 
14 N 
Anaesthetic and respiratory 
technology 
Director of Purchasing, Global 
Supply Chain 
Small and Medium 
Enterprise (SME) 
200 
15 O Hospital hardware Head of Outbound Logistics Large Enterprise (LE) 15 200 
1 = (GMDN-Agency, 2012) 
2= (Institut für Mittelstandsforschung (IfM), Bonn, 2017) 
 
A pilot study was conducted (Garcia-Villarreal et al, 2014). This study assisted the 
authors to generate a justification for the case research design, to implement appropriate 
adaptations of the data collection plans, and to prepare the next stages of the research on 
the basis of the pilot study’s empirical observations (Yin, 2009).  
The primary data collection utilised semi-structured interviews. Following Yin 
(2009), tests for construct validity, internal validity, external validity and reliability 
were performed. The data analysis was conducted in two steps: within case and cross-
case. All interviews were analysed following the three-step approach of Miles and 
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Huberman (1994). After individual firm profiles were obtained from within-case 
coding, a cross-case analysis was conducted (Yin, 2009). Coding was only regarded as 
complete once agreement between researchers was reached. 
 
 
Findings and discussion  
Six Critical Success Factors emerged as a result of the cross-case coding process. These 
are discussed in this section in detail. 
 
 Joint decision making to match demand and supply with S&OP  
Sales and Operations Planning (S&OP) is a both a cross-departmental and cross-
organisational process, as it ranges over all operational areas of an organisation and 
requires inputs of both key supplier and customers (Sheldon, 2006). S&OP is a key 
process working twofold: it first creates a good overview of future demand trends on the 
basis of a demand forecast and using input from sales and key customers; then it 
develops a plan in order to match the forecast against the organisation’s existing 
production and distribution capacities. Nine out of the 15 case companies provided 
strong evidence to support this factor as critical for success. Managers of almost all 
interviewed organisations have launched in recent years or are conducting at the 
moment improvement projects on this area. Forecasting is a core activity of sales and 
operation planning. Company D developed a tool to compare the current forecast plan 
with the available capacity budget of all business units, avoiding production 
bottlenecks, minimising the cost of unsold goods, and increasing on-time delivery to the 
end customer.  As pointed out by Company O, structure, rigour, and the appropriate 
information platform are required for a functional S&OP process. Here, they set up 
meetings with clearly defined responsibilities, increased executive participation and 
visibility, as well as an information management tool that allowed them to gather and 
feed the appropriate inputs to the process. Based on this, we propose that:  
P1 Issues of balancing customer demand requirements and capacity allocation in the 
supply chain are raised by conflicting goals between departments within an OEM and 
between organisations in the supply chain of German MT. MTSCs focusing on installing 
sustainable and robust Sales and Operation Planning systems have a competitive 
advantage over those who do not. 
 
Reduction of complexity in the design of products and manufacturing processes   
Medical technology is one of the most research-intensive industries in Germany 
(BVMed, 2015). The basis for the economic success of German medical technology in 
Germany and abroad is the broad range of innovative products it creates. For this 
reason, the product development process becomes crucial for the supply of innovative 
products to an organisation’s customers (Medina et al, 2013). Respondents consider this 
factor as highly critical, as the decisions made at the product development process stage 
account for 70-80% of the product’s final costs (Schönheit, 1997). In this context, 
designers play a major role in the setup of their supply chains and in their degree of 
complexity. Given the importance of the role of users in the design of products, 
Company D cooperates actively with surgeons in the design of medical devices and 
names their finished products after the physician that inspired them.  
Activities in product development process have an influence on the performance of 
other organisational functions, such as procurement, manufacturing, marketing and 
sales, and service (Schönheit, 1997). Company A launched a project to standardise 
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information flows between sales, product development, and procurement in order to 
reduce the risk of increasing their dependency to niche suppliers by increasing their 
supplier base. These efforts enhanced their material availability while reducing the risk 
of material obsolescence. Six out of the 15 organisations interviewed have been actively 
working on shifting the focus from ‘developing the best possible product’ (Push) to 
‘designing the most adequate product for physicians’ (Pull), an approach that required 
shifting paradigms present in German engineering organisations – getting away from a 
traditional engineer’s mentality (‘made in Germany’) to a more customer-oriented and 
thus economically meaningful approach to design. For these reasons, we propose that, 
P2. In order to reduce complexity of future operations, product design requires not 
only the involvement of physicians, health institutions, and regulatory agencies to 
enhance product functionality, but also the involvement of stakeholders of the supply 
chain, particularly manufacturing, sourcing, logistics, sales, and after sales services.  
 
Efficient tracking and tracing brings competitive advantage  
The medical technology sector is in a high pressure to deliver products that are safe and 
effective for patients. Due to the high demands regarding quality, traceability, and 
security, organisations are requested to deliver documented evidence that the quality 
criteria regarding processes and products have been fulfilled (BVMed, 2015) and that 
all manufactured parts can be re-traced, thus becoming an important issue in SCM. A 
factor rarely found in the reviewed SCM literature, ‘quality and compliance’ was 
regarded as critical for success by seven of the case study companies. Many decisions in 
SCM are influenced by these regulations, as errors can occur during the development, 
production, sterilisation, storage, transportation or utilisation of medical devices.  
Given the critical nature of medical devices and the potential harm failures during the 
production and distribution processes can cause, implementing effective tracking and 
traceability processes is critical.  Companies G, H, and N, all have designed, formalised, 
and validated processes and set up information management systems in line with the 
current technological trend of ‘Industry 4.0’. These systems are capable of collecting 
information and keeping track of products at all the stages of the supply chain (primary 
production by suppliers, incoming material, warehousing, production and assembly, 
sterilisation, warehousing, distribution, and utilisation by the customer) and represent an 
improvement over previous processes, which were characterised as being bureaucratic, 
time-consuming, and inefficient. With these insights in mind, we propose that: 
P3. As supply chain visibility is a capability that customers are increasingly willing 
to pay for, selecting the appropriate tools requires process orientation. Providing 
hospitals and clinics with real-time information on product and spare parts shipping 
status can provide a competitive advantage for MTSCs. 
 
Increasing leverage of OEMs with appropriate procurement strategies 
Both purchasing and materials management constitute basic strategic business processes 
critical for the success of SCM and not just a narrow support function to the overall 
business strategy. Although studies such as Bhakoo and Chan (2011) have investigated 
collaboration and e-commerce within healthcare, the medical technology devices has 
not been the focus. In the context of supply chain management, the employed 
procurement strategies play a major role in the creation of value for industries in the 
medical technology sector, as medical devices have a relatively short life cycle in 
comparison with products from other industries. Conventional procurement strategies 
(VMI, EDI, Just in Time, Supplier Kanban) are applied by almost all of the large 
enterprises in this research. All Case companies note that it is important to evaluate 
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procurement strategies from a holistic perspective and consider the impact these might 
have in other organisations in the supply chain. Company H warns on using low cost 
country sourcing as a procurement strategy, as lost margin can be generated at the very 
beginning of a project when suppliers cannot deliver the agreed quality. Geographical 
distance, language and intercultural issues can also become barriers as well. 
Power relationships also play a role in the selection of the appropriate suppliers in 
the medical technology sector. Case companies C, D, and K have implemented Just in 
Time strategies with several degrees of success as a means to reduce stocks, forcing 
their suppliers to deliver raw material and components in small quantities and on 
immediate basis. Furthermore, Case companies D, K, and O have implemented VMI, 
making suppliers responsible for both stock overflows and stock-outs of at the OEMs’ 
warehouse facilities. In contrast, Companies L and M, both SMEs, are not strong 
enough to put pressure on suppliers to adopt such practices. Hence, we propose that: 
P4. Although procurement strategies such as VMI, Kanban, and JIT appear to be 
more beneficial for large German firms with power over suppliers, SMEs require their 
procurement strategies to be based on the product lifecycle in order to reduce the risk 
of inventory obsolescence. Cooperation and process knowledge exchange is beneficial 
for both OEMs and upstream organisations when designing and implementing 
alternative procurement strategies.   
 
CRM positively affects the configuration and complexity of SC operations 
Customer relationship management CRM) assists organisations in mining available 
customer data and information in order to understand customer requirements and to 
improve their value propositions. This involves collecting and logically using customer 
and other relevant data to build a consistently superior customer experience and 
enduring customer relationships and an integration of processes, people, operations, and 
marketing capacities (Swift, 2000). Several respondents noticed that the relationship 
with end customers has turned more complex in recent years. For instance, Company C 
has noted a shift of the way they do business with their customers. In the past, they 
would show up directly at a hospital with a new product in hopes that it would enthuse 
physicians and purchasing managers with its features and, based on this, they would 
negotiate prices and number of units to deliver.  Nowadays they must negotiate prices 
with intermediaries such as Group Purchasing Organisations (GPOs). Healthcare 
providers turn to GPOs in order to save time and money necessary to negotiate 
thousands of individual contracts. This however, seems to make it harder for some of 
the interviewed OEMs to get first-hand information on customer needs. For these 
reasons, we propose that: 
P5. German MTSC firms require a shift from pure cost-orientation to service-
orientation in order to remain competitive in the market. This is not limited to the 
strategic involvement of physicians and managers in issues such as product design, but 
also by designing and implementing tailor-made concepts for logistical supply and after 
sales services.   
 
Speed to market and flexibility are imperative for MTSC firms’ production systems 
The objective of an integrated production system is to produce more products in the 
same or shorter time with less cost while ensuring the expected quality. This is possible 
when work cycles are as short as possible and all non-added value activities are 
eliminated or at the very least, reduced. This results in shorter lead times, less work-in-
process, and higher productivity for an organisation, which translates into a better 
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responsiveness of its supply chain (Schönheit, 1997). Company D mentions that a key 
element to achieve agile, flexible supply chains is a production system that supports 
them, especially when several links of the supply chain belong to the same firm. 
Concentrating on changing previous management culture, refining target systems and 
ensuring process orientation within the organisation where the key elements of the 
implementation of their production system in several sites. Focusing on added-value 
activities in the supply chain is critical and restructuring these activities can provide 
opportunities for improvement. Company M was on the verge of losing a customer due 
to late deliveries. After the implementation of a Lean Production System in all of their 
manufacturing plants worldwide (an endeavour that took almost two years), the 
company was able to improve their on-time-delivery rates by 30% while reducing their 
fixed costs by 20%. Slow and long supply chains hinder a company’s ability to respond 
quickly to customer demand and, as the life cycles of medical devices are very short, 
manufacturers face the risk of inventory obsolescence (Li et al, 2006). For this reason, 
both Companies C and H have focused on improving material flow by streamlining 
their value streams starting from their suppliers to their distribution centres. They also 
have focused on carefully defining the information requirements between organisations 
and the instruments used to transfer this information. Based on these findings, it is 
proposed that: 
P6. Agile production systems that focus on speed to market and flexibility are better 
suited to support German MT supply chains, as product life cycles are shorter than in 
other industries. However, consequences of these process changes should be agreed 
with upstream business partners in order to create win-win scenarios and long-lasting 
relationships. 
 
Conclusions  
MTSCs have received limited coverage in the existing SCM literature, subsumed by 
generic supply chain research interests. However, in light of the increasing recognition 
of the importance of healthcare systems, their efficiencies and effectiveness, MTCSs 
have a key contribution to make. This research is an initial attempt to contribute 
empirically and practically to not only the wider body of SCM literature, but also work 
on CSFs along with sectoral focus on medical technologies.  
This paper’s contribution to theory is threefold. Firstly, the findings indicate that 
there are six CSFs for German MTSC firms, prioritised as follows: (1) sales and 
operations planning, (2) product development process, (3) quality and compliance, (4) 
procurement strategies, (5) customer relationship management, and (6) production 
systems. CSFs have been the subject of previous research in the field of Supply Chain 
Management but none has investigated the important and growing MTSC sector, which 
recent literature has labelled as ‘supply chain laggards’ (Mayr, 2013); this study 
provides elaboration and practitioner insight from the perspective of both LEs and 
SMEs of the German MTSC sector. Thirdly, this paper also clarifies a shift in our 
understanding of the importance of several CSFs to practitioners, such as information 
management and inventory management, which have been previously been perceived as 
more important than they actually are. Importantly, this study highlights pre-eminent 
factors for the success of SCM which have not been adequately recognised by previous 
research in particular: quality and compliance, product development process, and the 
production system itself. This paper provides empirical evidence about which strategies 
are being used by practitioners in the MT sector in order to improve the performance of 
their supply networks. Each of the identified CSFs is summarised in testable 
propositions, which sever as a starting point for further scholarly inquiry. Managers can 
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use this work as a guideline to develop or restructure their own supply chain policies. 
The insights from the case study organisations documented in this research will be of 
interest to organisations both in and beyond this sector.  
 
Limitations and future research  
One limitation of this study is that the target group of the case study was the head of the 
SCM operation of each case company. Although researchers were involved in the 
discussions in order to overcome this limitation, the insights provided by this 
respondent group may not be representative of the perceptions of other stakeholders in 
the MTSC. An additional limitation is the fact that it only represents the context of 
German MTSCs. Future research into the medical technology sector should seek 
widening studies that include other countries in order to gain a better understanding of 
the MTSC as a whole and thus enhance the generalisability of the research findings.   
There is great scope for further research that would build upon work in this area. The 
first entails using the results of this research in order to compare and contrast MTSCs in 
the US and Japan. Such a study could assist in overcoming the lack of generalisability 
of this research and test the relationships established in this paper. Future research could 
also provide further investigation into the relationship between the identified CSFs and 
the results achieved after implementing strategies based on these factors.  
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